Associated Medical Professionals — research payments reported

By program year

4 rows

Year	Kind	Amount	Payments
2022	Research	$331	1
2021	Research	$50,335	6
2020	Research	$9,718	4
2019	Research	$27,480	9

Breakdown

Who paid Research payments · program years 2019–2022

Myovant Sciences Inc. $48,420 3 payments
Allergan Inc. $21,795 8 payments
Astellas Pharma Global Development $17,648 9 payments

Studies the money was for Research payments · program years 2019–2022

Hero Study Grant $48,420 3 payments
A Study Evaluating the Efficacy and Safety of BOTOX Intravesical Instillation in Patients with Overactive Bladder and Urinary Incontinence $21,005 7 payments
A Phase 2 Open-label Extension Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study $14,100 7 payments
A Multicenter, Single-Arm, Open-Label, Post-Marketing Safety Study to Evaluate the Risk of Seizure Among Subjects with Metastatic Castration-Resistant Prostate Cancer mCRPC Treated with Enzalutamide Who Are at Potential Increased Risk of Seizure $3,548 2 payments
A Study Evaluating the Efficacy and Safety of BOTOX Intravesical Instillation in Patients with Overactive Bladder and Urinary Incontinence $790 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.